Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael A. Desjardin currently holds 126,558 shares of Horizon Therapeutics Public Ltd Co (HZNP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael A. Desjardin has been a net seller of HZNP stock. They have purchased $0 and sold $12.2M worth of shares.
Michael A. Desjardin's most recent insider trade was on Oct 6, 2023, when they sold 126,838 shares at $116.50 per share.
Michael A. Desjardin serves as Executive at Horizon Therapeutics Public Ltd Co (HZNP). They have executed 70 insider transactions totaling $12.2M over their tenure at the company.
Michael A. Desjardin holds the position of Executive at Horizon Therapeutics Public Ltd Co, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
Michael A. Desjardin has shown a selling trading pattern, with $0 in total purchases and $12.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Michael A. Desjardin was on Oct 6, 2023, when they sold $14.8M worth of HZNP shares. This transaction involved 126,838 shares at $116.50 per share.
Michael A. Desjardin currently owns 126,558 shares of Horizon Therapeutics Public Ltd Co (HZNP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael A. Desjardin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael A. Desjardin has 70 Form 4 filings on record as an insider at Horizon Therapeutics Public Ltd Co.
Set alerts for Michael A. Desjardin and 40,000+ other insiders.